Shanghai Institute of Precision Medicine (SHIPM), Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Translational Medicine Research Center (TMRC), School of Pharmaceutical Sciences, Xiamen University, Xiamen, Fujian, China.
Aging (Albany NY). 2021 Feb 9;13(3):4674-4695. doi: 10.18632/aging.202562.
White matter lesions known as leukoaraiosis (LA) are cerebral white matter hyperintensities observed in elderly individuals. Currently, no reliable molecular biomarkers are available for monitoring their progression over time. To identify biomarkers for the onset and progression of LA, we analyzed whole blood-based, microRNA expression profiles of leukoaraiosis, validated those exhibiting significant microRNA changes in clinical subjects by means of quantitative real-time polymerase chain reactions and determined the function of miRNA in cell lines by means of microRNA mimic transfection assays. A total of seven microRNAs were found to be significantly down-regulated in leukoaraiosis. Among the microRNAs, hsa-miR-1972 was downregulated during the early onset phase of leukoaraiosis, as confirmed in independent patients, and it was found to target leukoaraiosis-dependent decreasing its expression in 293T cell lines. Functional enrichment analysis revealed that significantly dysregulated miRNAs-mRNAs changes associated with the onset of leukoaraiosis were involved in neurogenesis, neuronal development, and differentiation. Taken together, the study identified a set of candidate microRNA biomarkers that may usefully monitor the onset and progression of leukoaraiosis. Given the enrichment of leukoaraiosis-associated microRNAs and mRNAs in neuron part and membrane system, could potentially represent a novel target of hsa-miR-1972 in leukoaraiosis through which microRNAs are involved in the pathogenesis of white matter lesions.
脑白质病变又称脑白质疏松症(LA),是老年人脑白质高信号。目前,尚无可靠的分子生物标志物可用于监测其随时间的进展。为了鉴定 LA 发病和进展的生物标志物,我们分析了脑白质病变患者的全血 microRNA 表达谱,通过定量实时聚合酶链反应验证了临床患者中具有显著 microRNA 变化的生物标志物,并通过 microRNA 模拟转染试验确定了 miRNA 在细胞系中的功能。共发现 7 个 microRNA 在脑白质病变中显著下调。在 microRNA 中,hsa-miR-1972 在脑白质病变的早期发病阶段下调,在独立患者中得到证实,并发现其靶向脑白质病变依赖性基因,降低了 293T 细胞系中的表达。功能富集分析显示,与脑白质病变发病相关的显著失调 microRNA-mRNA 变化涉及神经发生、神经元发育和分化。总之,该研究确定了一组候选 microRNA 生物标志物,可用于监测脑白质病变的发病和进展。鉴于脑白质病变相关 microRNA 和 mRNAs 在神经元部分和膜系统中的富集,hsa-miR-1972 可能通过参与白质病变的发病机制,成为脑白质病变的一个新的治疗靶点。